SLC22A16 upregulation is an independent unfavorable prognostic indicator in gastric cancer

被引:12
|
作者
Zhao, Wenhua [1 ]
Wang, Yongbin [2 ]
Yue, Xin [3 ]
机构
[1] Peoples Hosp Juxian, Dept Clin Lab Diag, Rizhao 276500, Shandong, Peoples R China
[2] Matern & Child Hlth Care Hosp Laizhou, Clin Lab, Laizhou 261499, Peoples R China
[3] Matern & Child Hlth Care Hosp Zibo, Clin Lab, Zibo 255029, Peoples R China
关键词
gastric cancer; methylation; prognosis; SLC22A16; TRANSPORTER SLC22A16; CELLS; EXPRESSION; GROWTH; OCT6;
D O I
10.2217/fon-2018-0207
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim:To study the expression profile of SLC22A16 in gastric cancer (GC), its prognostic value and the potential mechanisms of its upregulation. Patients & methods: A retrospective study was performed by using data in the Human Protein Atlas and The Cancer Genome Atlas-Stomach Cancer (STAD). Results:SLC22A16 was significantly upregulated in GC tissues compared with normal stomach tissues. SLC22A16 upregulation independently predicted poor overall survival(hazard ratio [HR]: 1.424,95% CI: 1.169-1.735; p<0.001) and recurrence-free survival (HR: 1.658, 95% CI: 1.292-2.128; p<0.001) in early GC and poor overall survival (HR: 1.411, 95%CI: 1.137-1.752; p=0.002) in advanced GC. SLC22A16 DNA hypomethylation might be a compensation for DNA loss to maintain SLC22A16 elevation in GC. Conclusion:SLC22A16 might be a valuable prognostic marker in GC.
引用
收藏
页码:2139 / 2148
页数:10
相关论文
共 50 条
  • [41] Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma
    Chen, De
    Luo, Linjie
    Liang, Chao
    PLOS ONE, 2018, 13 (05):
  • [42] Expression of the organic cation transporter SLC22A16 can be a feature of human epithelial ovarian cancers with different histological type.
    Ota, K
    Akahira, JI
    Sato, N
    Moriya, T
    Unno, M
    Abe, T
    Ito, K
    Yaegashi, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 486S - 486S
  • [43] Reduced Galectin-3 expression is an indicator of unfavorable prognosis in gastric cancer
    Okada, K
    Shimura, T
    Suehiro, T
    Mochiki, E
    Kuwano, H
    ANTICANCER RESEARCH, 2006, 26 (2B) : 1369 - 1376
  • [44] Hyperthermia upregulates SLC22A16 expression and downregulates ABCG2 expression via ROS production and enhances the cytotoxicity of doxorubicin.
    Kurokawa, H.
    Ito, H.
    Matsui, H.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [45] Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells
    Feng, Xiaobo
    Zhu, Mei
    Liao, Bingling
    Tian, Tianning
    Li, Minhong
    Wang, Zhibo
    Chen, Guoyan
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (03) : 103 - 110
  • [46] The clinical application value of miR-1269 as an unfavorable prognostic indicator of lung cancer
    Le, Jinghong
    Le, Xiang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 3270 - 3277
  • [47] Stromal staining for PINCH is an independent prognostic indicator in colorectal cancer
    Gao, JF
    Arbman, G
    Rearden, A
    Sun, XF
    NEOPLASIA, 2004, 6 (06): : 796 - 801
  • [48] CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer
    Sawada, Genta
    Ueo, Hiroki
    Matsumura, Tae
    Uchi, Ryutaro
    Ishibashi, Masahisa
    Mima, Kosuke
    Kurashige, Junji
    Takahashi, Yusuke
    Akiyoshi, Sayori
    Sudo, Tomoya
    Sugimachi, Keishi
    Doki, Yuichiro
    Mori, Masaki
    Mimori, Koshi
    ONCOLOGY REPORTS, 2013, 30 (03) : 1137 - 1142
  • [49] Upregulation of proline rich 11 is an independent unfavorable prognostic factor for survival of tongue squamous cell carcinoma patients
    Wang, Chunyang
    Yu, Liang
    Hu, Fengchun
    Wang, Juan
    Chen, Xijuan
    Tai, Shanshan
    Cheng, Bin
    ONCOLOGY LETTERS, 2017, 14 (04) : 4527 - 4534
  • [50] Upregulation of shelterin and CST genes and longer telomeres are associated with unfavorable prognostic characteristics in prostate cancer
    Santos, Gabriel Arantes dos
    Viana, Nayara, I
    Pimenta, Ruan
    Camargo, Juliana Alves de
    Guimaraes, Vanessa R.
    Roma, Poliana
    Candido, Patricia
    Santos, Vinicius Genuino dos
    Reis, Sabrina
    Leite, Katia Ramos Moreira
    Srougi, Miguel
    CANCER GENETICS, 2024, 284 : 20 - 29